Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
XYence Capital SGR is an independent venture capital firm based in Milan, Italy, specializing in life sciences investments. Founded to support innovation in oncology and healthcare, the firm operates with a dual-fund structure that enhances its investment capabilities. XYence Capital SGR collaborates closely with academic and clinical entrepreneurs, aiming to drive advancements in the life sciences sector.
The firm currently manages two active funds and has a team of approximately six professionals, including four partners. XYence Capital SGR focuses exclusively on the Italian life sciences market, which positions it uniquely within the European investment landscape. The firm has established a reputation for identifying and supporting innovative companies that are developing groundbreaking therapies and technologies.
Notable milestones include successful exits from investments such as CrestOptics and TRIFARMA, showcasing the firm’s ability to navigate the complexities of the healthcare landscape. XYence Capital SGR continues to seek opportunities that align with its mission to foster development and innovation in life sciences.
XYence Capital SGR concentrates its investment strategy on the life sciences sector, with a particular emphasis on oncology and healthcare. The firm seeks to identify innovative companies that are developing novel therapies and technologies that can significantly impact patient care. XYence's investment approach is characterized by a strong collaboration with academic and clinical entrepreneurs, which enhances its ability to support groundbreaking advancements in the field.
While specific details regarding investment stages and check sizes are not disclosed, the firm’s dual-fund structure indicates a commitment to supporting both early-stage and growth-stage companies. XYence Capital SGR is particularly interested in companies that demonstrate a clear potential for innovation and market disruption within the life sciences domain. The firm’s focus on the Italian market allows it to leverage local expertise and networks, further enhancing its investment strategy.
XYence Capital SGR has built a diverse portfolio of 11 companies, primarily within the life sciences sector. Notable investments include:
These investments reflect XYence Capital SGR's commitment to supporting innovative solutions in healthcare and oncology. The firm’s track record of successful exits indicates its ability to identify and nurture companies with high growth potential.
To pitch XYence Capital SGR, founders should seek to establish a connection through industry events or professional networks. While specific channels for submission are not disclosed, a well-prepared pitch deck should include an overview of the business model, market analysis, competitive landscape, and financial projections.
Founders should be ready to articulate their technology's unique value and its potential impact on patient care. Response times may vary, so patience is advised after initial outreach.
What are XYence Capital SGR's investment criteria?
XYence Capital SGR focuses on investments in the life sciences sector, particularly in oncology and healthcare. The firm seeks innovative companies that are developing groundbreaking therapies and technologies.
How can I apply or pitch to XYence Capital SGR?
While specific application procedures are not disclosed, potential founders are encouraged to reach out through professional networks or industry events to establish connections with the firm.
What makes XYence Capital SGR different from other investors?
XYence Capital SGR specializes in the Italian life sciences market and collaborates closely with academic and clinical entrepreneurs, providing unique insights and support that are tailored to the complexities of the healthcare landscape.
What is the geographic scope of XYence Capital SGR's investments?
The firm focuses exclusively on the Italian market, allowing it to leverage local expertise and networks in the life sciences sector.
What is the typical check size for investments?
Specific check sizes are not disclosed, but the firm’s dual-fund structure suggests flexibility in supporting both early-stage and growth-stage companies.
What kind of post-investment involvement does XYence Capital SGR have?
XYence Capital SGR adds value to its portfolio companies by providing strategic guidance and leveraging its network of academic and clinical partners to help navigate the healthcare landscape.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.